CCL11 and chronic obstructive pulmonary disease: Eotaxin-1 levels, on the other hand, were significantly lower in the stable COPD group (Figure 5) compared to normal controls (p < 0.03) and trended lower in stable COPD subjects compared to those with rapidly progressive disease (p = 0.11).